Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Murthy

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Pediatric Pulmonology|March 25, 2005
Influence of socioeconomic status on lung function and prediction equations in Indian childrenP Sitarama Raju, K V V Prasad, Y Venkata Ramana, et al.
Indian Pediatrics|September 3, 2003
Study on lung function tests and prediction equations in Indian male childrenP Sitarama Raju, K V V Prasad, Y Venkata Ramana, et al.
Cytokine|August 28, 2010
Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humansV Hari Sai Priya, G Suman Latha, Seyed E Hasnain, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 2, 2005
Fluorescent amplified fragment length polymorphism (FAFLP) based molecular epidemiology of hospital infections in a tertiary care setting in Hyderabad, IndiaPrashanth Kenchappa, Kalashikam R Rao, Niyaz Ahmed, et al.
Plos One|November 1, 2008
The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune responseSmanla Tundup, Niteen Pathak, M Ramanadham, et al.
Bulletin of the World Health Organization|June 27, 2006
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from IndiaKatherine Floyd, V K Arora, K J R Murthy, et al.
Journal of Immune Based Therapies and Vaccines|June 9, 2007
Age-related waning of in vitro Interferon-gamma levels against r32kDaBCG in BCG vaccinated childrenB Anuradha, C M Santosh, V Hari Sai Priya, et al.
Infection and Immunity|October 24, 2003
PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell responseRakesh Kumar Choudhary, Sangita Mukhopadhyay, Prachee Chakhaiyar, et al.
Clinical and Vaccine Immunology : CVI|November 7, 2008
In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosisV Hari Sai Priya, B Anuradha, Suman Latha Gaddam, et al.
Tuberculosis (Edinburgh, Scotland)|May 25, 2011
Treatment end point determinants for pulmonary tuberculosis: human resistin as a surrogate biomarkerNasreen Z Ehtesham, Mohammad Nasiruddin, Ayesha Alvi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Pediatric Pulmonology|March 25, 2005
Influence of socioeconomic status on lung function and prediction equations in Indian childrenP Sitarama Raju, K V V Prasad, Y Venkata Ramana, et al.
Indian Pediatrics|September 3, 2003
Study on lung function tests and prediction equations in Indian male childrenP Sitarama Raju, K V V Prasad, Y Venkata Ramana, et al.
Cytokine|August 28, 2010
Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humansV Hari Sai Priya, G Suman Latha, Seyed E Hasnain, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 2, 2005
Fluorescent amplified fragment length polymorphism (FAFLP) based molecular epidemiology of hospital infections in a tertiary care setting in Hyderabad, IndiaPrashanth Kenchappa, Kalashikam R Rao, Niyaz Ahmed, et al.
Plos One|November 1, 2008
The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune responseSmanla Tundup, Niteen Pathak, M Ramanadham, et al.
Bulletin of the World Health Organization|June 27, 2006
Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from IndiaKatherine Floyd, V K Arora, K J R Murthy, et al.
Journal of Immune Based Therapies and Vaccines|June 9, 2007
Age-related waning of in vitro Interferon-gamma levels against r32kDaBCG in BCG vaccinated childrenB Anuradha, C M Santosh, V Hari Sai Priya, et al.
Infection and Immunity|October 24, 2003
PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong B-cell responseRakesh Kumar Choudhary, Sangita Mukhopadhyay, Prachee Chakhaiyar, et al.
Clinical and Vaccine Immunology : CVI|November 7, 2008
In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosisV Hari Sai Priya, B Anuradha, Suman Latha Gaddam, et al.
Tuberculosis (Edinburgh, Scotland)|May 25, 2011
Treatment end point determinants for pulmonary tuberculosis: human resistin as a surrogate biomarkerNasreen Z Ehtesham, Mohammad Nasiruddin, Ayesha Alvi, et al.
Pageof 3